Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PEOPLE - World Health Organization makes appointment:

This article was originally published in Clinica

Executive Summary

David Byrne is to become a special envoy for the World Health Organization (WHO) at the end of his tenure as European Commissioner for health and consumer protection. (That was due to be October 31, but Commission President-Designate Jose-Manuel Barroso decided on October 27 not to submit the new Commission for Parliament's approval, due to objections to the nomination of one Commission (human rights). A new Commission will now not be submitted for some weeks.) Mr Byrne's new role will be to facilitate the process of negotiation of a revised draft of regulations in view of the coming meeting of officials from WHO's 192 member states on November 1-12. The final draft will be presented to the world health assembly in May 2005.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT060068

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel